Term
|
Definition
class V- MISC
MOA:
1) inhibition of Na/K ATPase--> Less Na/Ca exchange----> ^ Ca sER--> contractility,
2)Indirect: inhibits Na/K-ATPase of neurons, depolarization of ANS -->
- PANS: lower HR, ^ diastolic filling--> ^SV
- SANS: ventricles ^ contractility
PK: long t1/2, renal clearance, binds tissue protein*
* Amiodarone, Propafenone, Quinidine, Verapamil
Side effect: Early: N/V/D late: visual (orange halos), disoriented
Toxic: arrhythmias, ECG: inverted T, ST depression, premature ventricular beats give antibodies, electrolytes and Class IB)
Electrolytes induce arrhythmias: low K, ^Ca(thiazide), low Mg (loops) |
|
|
Term
|
Definition
a-methyl-norepinephrine agoinst at presynaptic a2 in brainstem-->lowers SANS and lowers Bp by B1, a1 tone
1# for mild - moderate in PREGO
Adverse: positive Coombs test in 20% but not full blown hemolytic anemia |
|
|
Term
|
Definition
agoinst at presynaptic a2 in brainstem-->lowers SANS and lowers Bp by B1, a1 tone
useful in bp and opiate w/d |
|
|
Term
|
Definition
AntiHTN
irreversibly blocks VMAT, which transports NE,DA, 5-HT from being transported to vesicles--> depletion of NTs--> low SANS, LONG ACTING
Side Effects: Major depression-like syndrome |
|
|
Term
|
Definition
Anti-HTN
NE-transporter takes it up in vesicles so NE doesnt go in vesicles and its a fake
TCA block reuptake of guanethidine |
|
|
Term
doxazosin
terazosin
Prazosin |
|
Definition
antagonist of peripheral a1 ( relax ss )
not used for HTN due to first dose syncope, used for BPH, modestly lowers LDL and ^ HDL
tamusolin is very specific for prostate, no affect on vessels |
|
|
Term
|
Definition
prodrug of NO
safe in prego for mod-severe HTN
Side Effects: SLE-like syndrome (in slow acetylators), tachycardia, fluid retention
mild HTN in prego= methyldopa
NO--> ^^ guanylate cyclase--> cGMP--> PKC--> posphatase takes of P of MLC--> inactive
All direct vasodilators, when given alone will cause tachycardia (B1 blocker) and edema (give diuretic)
|
|
|
Term
|
Definition
NO prodrug also acts on veins
NO--> ^^ guanylate cyclase--> cGMP--> PKC--> posphatase takes of P of MLC--> inactive
IV for HTN emergency, slow infusion bc converted to cyanide (binds cytochrome C)
Antidote to cyanide poisoning: Sodium nitrite ( makes Heme's iron Fe2--> Fe3--> methemoglobin which CN loves) then Sodium thiosulfate (cosubstrate that chealates CN) |
|
|
Term
|
Definition
Direct vasodilator, Diazoxide sole use in insulinomas
opens ATP/K channel--> ^ hyperpolarized-->->-> ^ phosphatase
Potent, used for refractory HTN (HTN not responding to treatment like renal artery stenosis)
Side effect: Hypertrichosis, hyperglycemia (beta cells of pancreas also have ATP/K channels) |
|
|
Term
Dihydropyridine Ca Channel Blockers |
|
Definition
Amiodipine, Isradipine etc
L type Ca channels in vascular smooth muscle, doesnt act on heart
Adverse: Gingival Hyperplasia* except Isradipine, reflex tachy, lower edema
* Phenytoin, Ethosuximide, topiramate, valproate, cyclosporine |
|
|
Term
Non-dihydropyridine Ca Channel Blockers |
|
Definition
Verapamil, Diltiazem
Blocks cardiac Ca channels--> lower HR, contractility
HTN in patients with angina that cant tolerate B-blockers
Adverse: AV block, Heart failure, Constipation (verapamil) |
|
|
Term
|
Definition
--pril, Enalapril, captopril, etc
No angiotensin II --> lower afterload, efferent arteriolar dilation of kidney, lower aldosterone, ^ bradykinin (vasodilation, dry cough)
C/I : in bilateral renal artery stenosis, or if patient has 1 kidney. Prego
Side effects: Angioedema, hypotension, Hyperkalemia (lower filtration rate), NSAIDS potentiate renal dysfunction
|
|
|
Term
ANgiotensin II receptor Antagonists (ARBs) |
|
Definition
--sartan, Losartan etc
No effect on bradykinin, also causes efferent arteriolar dilation
C/I : in bilateral renal artery stenosis, or if patient has 1 kidney. Prego
Side effects: hypotension, Hyperkalemia (lower filtration rate), NSAIDS potentiate renal dysfunction |
|
|
Term
|
Definition
Inhibits enzyme renin
Adverse: hyperkalemia
|
|
|
Term
|
Definition
Brain natriuretic peptide analog--> guanylate cyclase--> ^ cGMP--> vasodilation, natriuresis--> low preload
Use: Acute Decompensated CHF |
|
|
Term
|
Definition
Endothelin receptor antagonist
ETa and ETb receptors
Use: Pul HTN, Cor Pulmonale ---Prevents vasospams
Side effect due to vasodilation: hypotension, ^ HR, flushing, headache |
|
|
Term
|
Definition
Endothelin receptor antagonist
ETa receptor
Use: Pul HTN, Cor Pulmonale-- Prevents vasospams
Side effect due to vasodilation: hypotension, ^ HR, flushingm headache |
|
|
Term
|
Definition
Phosphodiesterases inhibitor type V --> ^ cGMP--> dilation
Pul HTN, Cor Pulmonale, erectile dysfunction
Not w/ nitrates (too much relax) |
|
|
Term
3 Prostacyclin analogs
(prostaglandins--> vasodilation) |
|
Definition
Epoprostenol --- IV infusion
Iloprost, Treprostinil = inhalation
Gs--> cAMP--> PKA-- phosphatase--> MLC un-P
Pul HTN, Cor Pulmonale |
|
|
Term
|
Definition
Oral guanylate cyclase Activator
C/I: nitrates, PDE type V inhibitors
vasodilation
Pul HTN, Cor Pulmonale |
|
|
Term
Which classes of Heart drugs lower cardiac remodeling? |
|
Definition
ACE inhibitors
ARBs
a, B blocker
Diuretics |
|
|
Term
Isosorbide mono/di- nitrate (long)
Nitroglycerin (short except patch) |
|
Definition
Nitrate--> NO--> guanylate cyclase--> cGMP--> MLCP--> large vein dilation, arteriolar dilation, dilation of coronary arteries (minor)
Tachyphylaxis so drug free when sleeping
PDE5 inhibitors |
|
|
Term
|
Definition
Reduce MI, mortality and stroke risks
MOA: competative HMG-CoA reductase inhibitor causing ^ LDL hepatic receptors, lowers VLDL synthesis (cholesterol + triglyceride)
Adverse: Hepatotoxicity (If AST 3X normal), rhabdomyolysis (no farnesyl pyrophosphate= no coenzyme Q)
D-D: Inhibitors of P450,grapefruit red yeast rice (acts like statins) |
|
|
Term
Gemfibrozil
&
Fenofibrate |
|
Definition
PPAR-a agonists
Induce lipoprotein lipase--> lowers VLDL
lowers TGL (since VLDL is high in TGL) , ^ HDL
hypertriglyceremia
Adverse: Cholethiasis (more FA in bile), Hepatitis, Myositis (lower clearance of statins )
|
|
|
Term
Colesevelam
(name 2 more in class?) |
|
Definition
Bile acid sequestrants (cholesterol)
Cholestyramine, Colestipol
hepatic LDL receptor ^, clears LDL from plasma
some ^ HDL ....
^ VLDL synthesis so dont give to peeps with ^ TGL
Adverse due to fat malabsorption: G.I distress, Vit DAKE, |
|
|
Term
|
Definition
MOA: lowers production of VLDL, hence LDL
(probably inhibits hormone sensitive lipase)--> less release of fat b/t meals so liver maintains more fat and doest make VLDL --> ^ HDL ( no longer has to transfer cholesterol to IDL remnents
Adverse: flushing, pruritus from mast cells give aspirin before |
|
|
Term
|
Definition
MOA: blocks cholesterol at brush border
lowers LDL good w/ statin
doesnt impair absorption of TGL,fat vitamins |
|
|
Term
|
Definition
Antisense oligonucleotide against ApoB-100 mRNA
homozygous familial hypercholesterotemia |
|
|
Term
|
Definition
irreversible acetylation of COX-1--> less TXA2--> no platelet activation
Adverse: GI distress, bleeding |
|
|
Term
Cloidogrel
(can you name others) |
|
Definition
Ticlopidine, Prasugrel, Ticagretor
Inhibits P2Y-12 receptor so ADP can not bind (normally: ADP--> lowers cAMP--> platelet activation) |
|
|
Term
|
Definition
Eptifibatide, Tirofiban
Inhibits IIb/IIIa (binds fibrinogen)
Adverse: bleeding |
|
|
Term
|
Definition
Selective vasodilators of cardiac vessels also
Cilostazol, adenosine (steal from hypoxic areas)
Inhibits cAMP/cGMP phosphodiesterase inhibitors--> ^ cAMP (no aggregation) and ^cAMP or cGMP = vasodilation
Diapyridamole: alternative to treadmill for cardiac stress test.
|
|
|
Term
|
Definition
large, water soluble
IV, SubQ, multi-organ elimination, T1/2: 2 hrs
ok for prego
MOA: catalyzes antithrombin III binding to IIa, IXa, Xa, XIa, XIIa----moniter PTT
Antagonist: Protamine sulfate
Use: in hospital
adverse: HIT (antibody to heparin + platelet factor 4)* , bleeding, osteoporosis, hypersensitivity
* give: argatroban, lepirudin = direct thrombin inhibitor |
|
|
Term
|
Definition
small, lipid soluble-- Heparin first
Oral, 98% bound to protein (sulfonamides displace) , liver metabolism, T1/2: 30 hrs, not in prego.. PT monitoring
MOA: inhibits vit K epoxide reductase--> no y-COOH--> no II,VII,IX,X, protein C (V,VIII)/S
Outpatient
antidote: Vit K (slow), fresh frozen plasma (fast)
Adverse: Skin necrosis ( if low C, since its supressed 1st), teratogenic
Lower efficary (low PT): lipid malabsorption ( cholestyramine, colestipol, colesevelam), Antacids, green leafy vegs ( ^ K, competes),inducers
^ efficacy: inhibitors, synergistic (aspirin, heparin, 3rd gen cephalosporins)
|
|
|
Term
|
Definition
Low molecular weight heparins
Enoxaparin
Increased activity against Xa (not PTT but moniter Xa)
|
|
|
Term
|
Definition
low molecular weight heparin
selective antithrombin III mediated Xa inhibition
|
|
|
Term
|
Definition
Streptokinase
activates plasminogen to plasmin
|
|
|
Term
E- aminocaproic acid
(1?) |
|
Definition
Antifibrinolytics
tranexamic acid
inhibits competatively plasminogen activation |
|
|
Term
|
Definition
Dronabinol
(Neuronal) CB1> CB2 (PNS)
Antiemetic (low 5-HT3 stimulation), anorexia or cachexia ( low leptin)
|
|
|
Term
|
Definition
MOA: Binds PBP aka transpeptidase--> prevents transpeptidation, inhibits cross linking (all B-lactams)
PK: unmetabolized through kidney
(ex: Nafcillin, Oxacillin, dicloxacillin = bile)
Resistance: B-lactamases, methicillin resistance = weak PBP binding.
Adverse: hypersensitivity, pseudomembranous colitis (ampicillin)
Additives: clavulanic acid, sulbactam, tazobactam & probenecid |
|
|
Term
|
Definition
sensitive, narrow syphilis (P/L chancre) |
|
|
Term
|
Definition
sensitive, narrow GAS---pyogenes |
|
|
Term
Methicillin
(3 others, NOD) |
|
Definition
B-lactamase resistant penicillins, only anti-staph not used bc interstitial nephritis,(Typer III) used to see if it works, because if its resistant than its due to PBP shape change
Nafcillin
Oxacillin
Dicloxacillin
MRSA: vancomycin--> linezolid or quinupristin/ dalfopristin |
|
|
Term
|
Definition
Aminopenicillins: B-lactamase Sensitive, Broad
IV
G+, G-
Used for suspected L. meningitis
Nonallergic rash (mono)
Combo w:
- Aminoglycosides: (synergy, lower resistance especially endocarditis)
- sulbactam |
|
|
Term
|
Definition
Aminopenicillins: B-lactamase Sensitive, Broad
G+, G-
oral
ottis media, CAP, sinusitis, GI,GU
Combo w:
- Aminoglycosides: synergy, lower resistance especially gentamicin for (enterococcal) endocarditis
- Clavulanic acid- suicide inhibitors, not antibiotics combo for prophylaxis in dog, cat, human bites
|
|
|
Term
Carbenicillin
Ticarcillin
Piperacillin
Azlocillin
|
|
Definition
B-lactamase sensitive, Extended spectrum
Anti-pseudomonal
IV |
|
|
Term
Cefazolin
Cephalexin
(if it has ph its a 1st generation)
|
|
Definition
First gen cephalosporins
MOA & resistance : same as penicillin
excreted unchanged in kidney (bile excretion: nafcillin, oxacillin)
G+ cocci, E. coli, K. pneumoniae, Proteus mirabilis
Cefazolin used for surgical prophylaxis
Adverse: Hypersensitivity (give macrolides or aztreonam for G- rods only) |
|
|
Term
Cefuroxime
Cefotetan, Cefoxitin
Not that important, not used often
|
|
Definition
2nd gen cephalosporins
MOA & resistance : same as penicillin
excreted unchanged in kidney
more G- than G+
Active against Beta lactamse producing H. influenza, K. pneumoniae, penicillin resistant streptococci
Cefamandole, cefotetan only = Disulfiram-like & less Factor II
Disulfiram: any drug that has the word azole (here is exception)
|
|
|
Term
Cefixime, Cepodoxime, Cefotaxime
Ceftazidime, Ceftriaxone, Ceftizoxime
( it T after F, its 3rd gen)
|
|
Definition
3rd gen cephalosporins
MOA & resistance : same as penicillin
excreted unchanged in kidney, ceftriaxone= bile
not for LAME: Listeria, Atypical, MRSA, Enterococci
( give: ampicillin, macrolide, Vancomycin, Ampicillin + aminoglycogin or vancomycin respectively)
empirical mgmt of meningitis and sepsis
|
|
|
Term
|
Definition
4th gen cephalosporins, resistant to most B-lactamses
MOA & resistance : same as penicillin
excreted unchanged in kidney
Adverse: FOR ALL cephalosporins, Hypersensitivity give macrolides(G-/G+) or aztreonam for G- rods only |
|
|
Term
Imipenem/Cilastatin
Meropenem, Doripenem, Ertapenem |
|
Definition
Carbapenems: most potent lactam antibiotic, resistant to beta lactamases
Cilastatin: inhibits renal enzyme dehydropeptidase that converts Imipenem to toxic: seizures.... others dont need it
Severe nosocomial infections |
|
|
Term
|
Definition
Monobactam
( no cross allergy w/ cepha, penicillin)
MOA: same as penicillin
G- rods only, including pseudomonas |
|
|
Term
|
Definition
Glycopeptide
MOA: binds D-ala-D-ala, no transglycosylation--> no elongation of peptide (NOT transpeptidation, cross linking)
IV or drink for difficile , renal clearance
Telavancin also disrupts bac cell membrane
MRSA, Enterococci (D-ala-D-lactate = VRE)
(similar resistance VRSA)
Adverse: Ototoxicity, Nephrotoxicity, Red man--> histamine release w/ fast infusion--> rash on face, upper torso w/ drop in BP (type I, also give diphenhydramine) |
|
|
Term
|
Definition
Antibiotic, Lipopeptide
alternative to vancomycin= G+ cocci
MOA: inserts in plasma membrane--> disruption
IV, renal clearance
Adverse: allergic, rhabdomyolysis moniter CK |
|
|
Term
|
Definition
MOA: prevents de-P of a lipid carrier* used to transport peptidoglycan building blocks
*isoprenyl pyrophosphate/bactoprenol
topical
G+ bac
Adverse: severe nephrotoxicity in IV |
|
|
Term
Gentamicin
Gent K.A.N.T.S |
|
Definition
Aminoglycoside: Bactericidal
Streptomycin, Amikacin, Neomycin(topical) , Tobramycin, Kanamycin
Needs 02-dependent uptake,
Used:
Ampicillin + gentamicin = E. faecalis, listeria
Vancomycin* + Gentamicin = E. Faecium
Antipseudo penicillin or 3rd cephalosporin or carbapenem + aminoglycoside
TB & bubonic plague
MOA: binds 30S at P site, inhibits initiation complex and causes misreading
1 daily dosing to lower toxicity since bactericidal, conc dependent killing and time dep toxicity
Resistance: Transferases (conjugation), change porin channels(entry), change in rRNA (30S)
Adverse: ototoxicity, (ethycrinic acid) Nephrototoxicity*, NMJ blockade at ^ doses, dermatitis for neomycin |
|
|
Term
Doxycycline
vs
Minocycline |
|
Definition
Tetracycline, Demeclocycline
Passive diffusion so broad
ALL bac + protoza
Absorption is prevented by *(Ca, Mg, Fe2+, Al3+)- dairy, antiacids, supplements
Renal and bile clearance
MOA: 30S A site ( inhibits elongation)
Doxycycline more lipid soluble so DOC: Vibrio, Spirochete(rickettsia, borrelia) , Mycoplasma, Chlamydiae, Brucella (w/ rifampin)
Mino is very water soluble in tears, saliva= asymptomatic meningococcal carriers, Doxy is lipid and not cleared by renal
TCA resistance: pumps increasing efflux, change in ribosome binding site, inactivates enzyme
Adverse: ^^ clostridium, *bone and teeth(enamel hypolasia or permanent tooth discoloration,photosensitivity**, Demeclocycline (ADH receptor blocker used in SIADH, so never used as ATX)
** Quinolones, Sulfonamides (rash due to sun) |
|
|
Term
|
Definition
similar to Tetracycline
IV hospital setting ( ^ mortality)
MOA: Binds 30S A site
renal, bile clearance
MRSA, VRE,VISA not effective against pseudomonas, proteus
|
|
|
Term
|
Definition
MOA: binds 50S, P site (initiation)
VRE, nosocomial pneumonia, skin infections
Adverse: Anemia, thrombocytopenia, neutropenia, weak MAO inhibitor so Serotonin syndrome with SSRI
|
|
|
Term
Quinupristin/Dalfopristin |
|
Definition
bactericidal
Dalfopristin changes shape in A site-->^ quinupristin binding (elongation) 50S
VRE. faecium not E. faecalis
skin infection of s.aureus, S. pyogenes
inhibit 3A4
Adverse: infusion related (pain at IV, flu-like) |
|
|
Term
Azithromycin
(this one has long T1/2) |
|
Definition
Macrolides
Clarithromycin, Erythromycin, Tellthromycin, Ketolide: Telithromycin: CAP, effective in macrolide resistant strains, inhibits 3A4
hepatic,bile clearance, inhibits 3A4 except Azithromycin and has long half life reason given for chylamydia over doxycycline
MOA: binds 50S, translocation
Broad
DOC: C. diphtheriae, Legionella, Campylobacter
Macrolides resistance: CH3-- of 50s rRNA by methylases, efflux pumps
Adverse: Stimulates motilin receptors ( less w/ Clarithro), QT prolongation, cholestasis w/ erythro
|
|
|
Term
|
Definition
MOA: Binds 50S, translocation
G+ cocci & anaerobes*
DOC: aspiration pneumonia*
good distribution: bone, skin, tendon good for osteomyelitis S.aureus (osteomyelitis with G- quinolones)
C. diffucile colitis |
|
|
Term
Chloramphenicol
Phen= lipid soluble (oral, brain, metabolize in liver probably blocks with P450s. |
|
Definition
Broad spectrum antibiotic
Inhibitor of P450
MOA: binds 50S (Transpeptidase enzyme)
wide spectrum--- backup drug
hepatic clearance
Adverse: fatal blood dyscrasias, gray baby syndrome (cant conjugate, this drug nees glucuronidation) |
|
|
Term
Primethamine- Sulfadiazine |
|
Definition
Sulfonamides (usually given with DHF reductase inhibitors to--] dihydrofolate reductase, ONLY IN BAC)
DHFR: T,A,G
Broad spectrum(G+, G-,chlamydia),DOC: toxoplasmosis
Bacteriostatic
PK: High albumin binding, displaces bilirubin, liver metabolism
MOA: inhibits dihydropteroate synthase (PABA analogs)
Resistance is common: affinty for synthase, ^efflux, less influx, ^ PABA (Staph)
Adverse: Acute hemolysis in G6PD patients, Hypersensitivity: stevens johnson, photosensitivity |
|
|
Term
Trimethoprim
vs
Pyrimethamine |
|
Definition
Dihydrofolate Reductase Inhibitors
given with sulfonamides for synergy
Trimethoprim is for prokaryotes other is for protozoa
May cause BM suppresion with folate deficient patients |
|
|
Term
Trimethoprim-Sulfamethoxazole |
|
Definition
Sulfonamides (usually given with DHF reductase inhibitors to--] dihydrofolate reductase)
Broad spectrum(G+, G-,chlamydia), Enterobac, community acquire MRSA
DOC: Haemophilus, Nocardia, P. jiroveci (prophylaxis)
Bacteriostatic
PK: High albumin binding, displaces bilirubin*, liver metabolism
MOA: inhibits dihydropteroate synthase (PABA analogs)
Resistance is common: affinty for synthase, ^efflux, less influx, ^ PABA (Staph)
Adverse: Acute hemolysis in G6PD patients, fetal kernicterus in neonates*,Hypersensitivity: stevens johnson, photosensitivity |
|
|
Term
|
Definition
Sulfonamides
Ulcerative colitis
Gut bac--> Sulfapyridine (absorbed) + 5-aminosalicyclic acid (NSAIDs for gut)
Bacteriostatic
PK: High albumin binding, displaces bilirubin*, liver metabolism
MOA: inhibits dihydropteroate synthase (PABA analogs)
Resistance is common: affinty for synthase, ^efflux, less influx, ^ PABA (Staph)
Adverse: Acute hemolysis in G6PD patients, fetal kernicterus in neonates*,Hypersensitivity: stevens johnson, photosensitivity |
|
|
Term
Ciprofloxacin- seizures
Ofloxacin
Levofloxacin
Norfloxacin
Moxifloxicin
Gemifloxacin
Moxi, gemi more G+ then those underlined even cipro resistant S. pneumonia , G->G+ |
|
Definition
Quinolones
MOA: block topoisomerase II (G-), Topoisomerase IV G+,
Bactericidal
Resistance: change in topoisomerase, ^ efflux pump
Use: UTI and gastroenteritis alternative to TMP-SMX, DOC in shigella, Cipro= anthrax, Osteomyelitis, septic arthritis, skin infections of G- DM, ss
PK: renal clearance, multivalent cations lower absorption
Inhibits P450 1A2: ^ TCA, clozapine, theophylline
Adverse: tendonitis & rupture (C/I children, prego), photosensitivity ^QT: levo, gemi, moxi |
|
|
Term
|
Definition
Antiseptic
UTI's for E.coli, Enterococci
Prodrug, bac activate--> DNA damage
brown urine
Adverse: G6PD hemolysis |
|
|
Term
Rifamycin
Rifampin
(one question gives ask, which one for tb, answer is the one with most combination of drugs possible |
|
Definition
|
|
Term
|
Definition
Antiprotozoal DOC: Giardia, Trichomonas, Entamoeba
Antibacteria DOC: Bacteroides, C. difficile
Prodrug--> nitro radical kills anaerobes
Adverse: Metallic taste*( dysgeusia) , Disulfiram-like
SJS w/ menbendazole
|
|
|
Term
|
Definition
Basic Peptides (detergent) for G-
topical |
|
|
Term
|
Definition
topic
G+ cocci including MRSA
MOA: blocks isoleucyl-tRNA synthetase |
|
|
Term
|
Definition
MOA: Guanosine analog, first P by viral thymidine kinase--> chain termination, no 3'OH
Use: HSV1, HSV2, VZV,
Resistance: Absence or less viral TK
Pk: goes to CSF, Valacyclovir is prodrug
Adverse w/ IV: Nephro, neuro, thrombocytopenia w/ valacyclovir
|
|
|
Term
|
Definition
Oral prodrug needs v-Tk activation,
Guanosine analog
not a chain terminator, has 3'OH so competative
HSV1,2 VZV |
|
|
Term
|
Definition
guanosine analog prodrug needs viral phosphotransferase UL97* for 1st P, chain terminator (also can use v-TK)
Disseminated CMV, CMV retinitis Tx and prophylaxis (transplants)
* resistance
Pk: introcular implant, valganciclovir is prodrug (oral)
Adverse: BM suppression (dose limiting)-- give filgrastim |
|
|
Term
|
Definition
pyrophosphate analog
MOA: blocks v-DNA pol*, v-RNA pol
* resistance
IV
used for ganciclovir CMV or acyclovir resistant HSV, VZV
Adverse: Nephrotoxicity & hypoCa2+, IV pentamidine ^ risk of hypo Ca ( arrhythmia, tetany, seizures) |
|
|
Term
|
Definition
fusion Inhibitor
HIV-1
MOA: binds gp41
|
|
|
Term
|
Definition
MOA: CCR5 antagonist so that gp41 can bind
tropism testing wont work w/ CXCR4 or mixed
HIV-1
substrate 3A4
Adverse: Upper Resp infection, hepatotoxicity |
|
|
Term
|
Definition
MOA: inhibits integrase pol
HIV
metabolized by glucoranation* not P450
Adverse: myopathy, rhabdomyolysis** (check CK)
*blocked by atazanavir, indinavir
** statins (coQ), Daptomycin |
|
|
Term
Zidovudine
( + lamivudine given to healthcare pros) |
|
Definition
Competitive Nucleoside reverse transcriptase inhibitor (NRTIs), chain termination
Thymidine analog, activated by cellular kinases
Resistance is based on the analogs
HIV 1,2
Adverse mitochondria toxic (DNA pol-y): lactic acidosis, hepatitis,pancreatitis, P. neuropathy, BM suppression, myopathy |
|
|
Term
|
Definition
Competitive Nucleoside reverse transcriptase inhibitor (NRTIs), chain termination
Thymidine analog, activated by cellular kinases
HIV 1,2
Adverse mitochondria toxic: P. neuropathy, Fat wasting, avoid didanosine ( additive neuropathy, fatal pancreatitis), avoid zidovudine (competes) |
|
|
Term
|
Definition
Competitive Nucleoside reverse transcriptase inhibitor (NRTIs), chain termination
Cytosine analog, activated by cellular kinases
HIV 1,2, HBV
Adverse mitochondria toxic: not so toxic hyperpigmentation of skin |
|
|
Term
|
Definition
Competitive Nucleoside reverse transcriptase inhibitor (NRTIs), chain termination
Cytosine analog, activated by cellular kinases
HIV 1,2, HBV
Adverse mitochondria toxic: least toxic, avoid with emtricitabine (competes) |
|
|
Term
|
Definition
Competitive Nucleoside reverse transcriptase inhibitor (NRTIs), chain termination
Adeanine analog, activated by cellular kinases
HIV 1,2
Adverse mitochondria toxic: P. neuropathy, pancreatitis (avoid stavudine) |
|
|
Term
|
Definition
Competitive Nucleoside reverse transcriptase inhibitor (NRTIs), chain termination
Adeanine Nucleotide analog, but still prodrug activated by cellular kinases
HIV 1,2, HBV
blocks metabolism of didanosine ( ^ AUC)* , do not give together
Adverse mitochondria toxic: * pancreatitis, neuropathy |
|
|
Term
|
Definition
Competitive Nucleoside reverse transcriptase inhibitor (NRTIs), chain termination
Guanosine analog, activated by cellular kinases
HIV 1,2
Adverse: Hypersensitivity: fever, ab pain, rash w/in 1st 6 wks (restarting on abacavir --> shock, death) screened with linked to HLA B5701 |
|
|
Term
|
Definition
NNRTI
noncompetitive inhibitor of RT,not a prodrug
HIV-1
Metabolized by CYP450-3A4
Inducer of 3A4
Adverse: skin rash-stevens johnson, liver toxicty |
|
|
Term
|
Definition
NNRTI
noncompetitive inhibitor of RT
Rilpivirine: less CNS symptoms
HIV-1
not a prodrug, Metabolized by CYP450-3A4
Inducer of 3A4
Adverse: skin rash, stevens johnson,
CNS: nightmares, psychosis, teratogen, |
|
|
Term
|
Definition
NNRTI
noncompetitive inhibitor of RT, not a prodrug
HIV-1
Metabolized by CYP450- 3A4
Inhibitor of CYP450-3A4
Adverse: skin rash, stevens johnson |
|
|
Term
|
Definition
competative HIV aspartyl protease inhibitor
PD: least insulin resistnace ( ^lipids, ^ glucose,cushing-like) (proinsulin)
PK: All are cleared by 3A4*, All induce 3A4*, inhibits glucuronidation--> hepatotoxicity--> ^ indirect bili (also indinavir, tipranavir)
^ inhibitor but not inducer |
|
|
Term
|
Definition
competative HIV aspartyl protease inhibitor
PD: insulin resistnace ( ^lipids, ^ glucose,cushing-like) (proinsulin)
PK: All are cleared by 3A4*, All induce3A4*, inhibits glucuronidation--> hepatotoxicity--> ^ indirect bili (also indinavir, tipranavir)
nephrotoxicity, nephrolithiasis
|
|
|
Term
|
Definition
competative HIV aspartyl protease inhibitor
PD: insulin resistnace ( ^lipids, ^ glucose,cushing-like) (proinsulin)
PK: All induce 3A4*,
PK: hepatic clearance P450-2C19,
|
|
|
Term
|
Definition
competative HIV aspartyl protease inhibitor
PD: insulin resistnace ( ^lipids, ^ glucose,cushing-like)-
PK: hepatic clearance P450-3A4, Strong inhibition 3A4 and 2D6
|
|
|
Term
|
Definition
Enzyme: Adenylate cyclase 2nd msg: ^ cAMP Protein kinase: PKA B1, B2, D1, glucagon, H2, V2 LH, FSH, TSH, PTH |
|
|
Term
|
Definition
Enzyme: lower Adenylate cyclase 2nd msg: cAMP Protein kinase: PKA
a2,M2, D2, opiate, GABA-B, 5-HT1 |
|
|
Term
|
Definition
Enzyme: + PLC 2nd msg: ^ IP3, ^ DAG, ^ Ca Protein kinase: PKC
a1,M1,M3,AT1,H1,V1, 5-HT2 |
|
|
Term
|
Definition
In endo: Gq--> NO synthase--> Arginine--> NO goes into SS--> ^ cGMP which de-P myosin light chains and cant interact with actin |
|
|
Term
Receptors that are transmembrane enzymes |
|
Definition
Tyrosine kinase: growth factor receptors and insulin ( inhibitors --tinib)
Guanylate cyclase: fam of natriuretic peptides --> ^ cGMP |
|
|
Term
|
Definition
also EPO, somatotropin, interferons
receptor--> Janus kinase--> p-lates STAT which dimerize and are gene transcription modulators |
|
|
Term
|
Definition
|
|
Term
|
Definition
Methacholine : M =N, ACHE hydrolysis ++ Bethanechol: M >N Dx: asthma Pilocarpine: M, glaucoma
ACh Carbachol, M=N, glaucoma Cevimeline : M3 sjogen |
|
|
Term
AChE Inhibitors R,D,E,N,P,P,O, nerve gas toxicity? |
|
Definition
Rivastigmine, Donepezil- Alzheimer, Parkinson's dementia Edrophonium- Dx: MG, DDx: MG or crisis
Neostigmine: Tx: MG
Pyridostigmine: reverse competitive NMJ block: post GI, GU retention
Physostigmine: antiACh toxicity, cross BBB
Nerve gas: Tabun, sarin, soman
Organophosphates=(Malathion, parathion, diazinon,chlorpyrifos) give atropine, pralidoxime to save AChE |
|
|
Term
Atropine
( I,S,B,Toi,C,Tri,O,Tro) |
|
Definition
Atropine-- long acting, 3 amine so brain Ipratropium- asthma Scopolamine-- motion sickness,short term memory block (date rape) Benztropine-- parkinsons, enters CNS Tropicamide, Homatropine, cyclopentolate, Tiotropium, trihexypherydyl, Oxybutinim, Toiterodine-- bladder spasm, urinary incontinence Dicyclomine - IBD |
|
|
Term
|
Definition
Hexamethonium Mecamylamine Varenicline is a Nn partial agonist, quit smoking |
|
|
Term
|
Definition
Succinylcholine Suxamethonium these are neuromuscular blockers |
|
|
Term
|
Definition
|
|
Term
Botulinum vs Vesamincol vs Hemicholinium |
|
Definition
lowers release of ACh vs lowers vesicular uptake vs lowers choline uptake |
|
|
Term
Isoniazid
(5 side effects)
1st tb: Isoniazid, rifampin, pyrazinamide, ethambutol
2nd: streptomycin, cycloserine, quinolone |
|
Definition
Bactericidal
Prodrug: activated by cat peroxidase (KatG) a heat sensitive catalase, inhibits mycolic acid synthesis
block enoyl- carrier protein reductase, B-ketoacyl-ACP synthase
Resistance: mutation in KatG gene
Adverse: hepatitis, P. neuropathy, seizures (give B6--> low GABA), SLE in slow acetylators, hemolysis in G6PD
MCC of iatrogenic sideroblastic anemia: B6 for 0-aminolevulinic acid synthase, chronic alcohol is MCC that is not aitrogenic |
|
|
Term
|
Definition
Bactericidal
Rifabutin: M. avium intracellular (w/ Macrolides, ethambutol)
TB, erradication of asymptomatic meningococcal carrier,H influenza meningitis, with vancomycin or B-lactams for staph endocarditis, osteomyelitits
blocks DNA dep RNA pol ( b-subunit of prokaryotic RNA polymerase), blocks transcription
orange red color: all fluids
inducer of P450, hepatotoxicity |
|
|
Term
|
Definition
Anti-TB
prodrug, kills bac in lysosomes
Adverse: gout, hepatotoxicty
|
|
|
Term
|
Definition
anti-TB
bacteriostatic
inhibits arbinosyltransferase (prevents arabinogalactan synthesis, cell wall)
Adverse: Optic neurits ( red, green blindness, blurry) |
|
|
Term
Capreomycin
Cycloserine
(rare on exam) |
|
Definition
inhibits RNA synthesis -- nephro, ototoxicity
inhibits mycobac cell wall sinthesis by blocking peptide formation---seizures
|
|
|
Term
TB treatment for:
prophylaxis
active tuberculosis
Prego |
|
Definition
Isoniazid for 6 months
vs
4 drug regimen until sensitivity is known:
isoniazid*, rifampin*, pyrazinamide, ethambutol
then: * for nine months or ___ for 6 months
Prego: isoniazid, rifampin, ethambutol |
|
|
Term
|
Definition
sulfonamide
Leprosy, bites from brown recluse spider bite
dihydropteroate synthetase inhibitor, competes with para aminobenzoate (PABA)
|
|
|
Term
fungus treatment
Histopaslmosis, Blastomycosis, coccidiodiosis- Itraconazole
Aspergillosis: voriconazole
Candidiasis: Fluconazole
Zygomycosis ( mucor): control DM, posaconazole
Pneumocystosis: TMP-SMX
Cryptococcosis: Amphotericin B + Fluconazole
|
|
Definition
|
|
Term
|
Definition
Wide spectrum, very toxic
Binds ergosterol --> pores
resistance low ergosterol in membrane
IV no CNS, need intrathecal
Infusion related: fever, chills, hypotension--> due to histamine release ( NSAIDs, anti-H, corticoids)
MOST Nephrotoxicity: chronic renal failure ( low EPO, renal tubular acidosis, normochromic normocytic anemia, glomerulus damage) |
|
|
Term
Ketoconazole (Imidazole)
Miconazole, clotrimazole
vs
Fluconazole (triazoles- less effec on human steroid synthesis)
itraconazole, voriconazole, posaconazole |
|
Definition
Inhibit fungal CYP450 enzyme 14a-sterol demethylase* last step in ergosterol synthesis
* resistance: mutation in candida
oral, IV, fluconazole CSF
inhibitors of CYP450
Adverse: drug interactions, can lower androgen, cortisol
|
|
|
Term
|
Definition
Activated by funcal cytosine deaminase to 5-fluorouracil --> blocks thymidylate synthase, disrupts DNA synthesis
BM suppression |
|
|
Term
|
Definition
block B-glucan synthase
IV |
|
|
Term
|
Definition
Oral, topical
superficial mycosis
inhibits fungal squalene epoxidase (first step in ergosterol synthesis |
|
|
Term
|
Definition
Superficial mycosis
oral
binds microtubules (mitosis) only goes to keratin ( hair, nails, skin)
|
|
|
Term
Combination Therapy for HIV
Health care professional?
Prego? |
|
Definition
Most common intial: Tenofovir and emtricitabine +
raltegravir or
Efavirenz or
atazanavir w/ ritonavir boost
elvitegravir w/ cobicistat ( - 3A4 only) boost
Health care Pros: zidovudine + lamivudine for 1 month
Prego: Zidovudine throughout and to infant ( same effective if started at labor, no breast feeding) |
|
|
Term
|
Definition
Inhibit uncoating of influenza A block M2 proton channel of virus (pandemics)
Adverse: atropine like, livedo reticulars (DA, edema)
used in parkinsons (^ M, ^ DA)
|
|
|
Term
Zanamivir- inhaled
Oseltamivir - oral |
|
Definition
Inhibits Neuraminidases of influenza A and B
(analog of sialic acid compete with hemagglutinin binding)
Prophylaxis |
|
|
Term
|
Definition
^^^ALT/^AST ( alchol is opp)
Nucleoside/neculeotide analogs, interferon a
1st line:
pegylated interferon a
activate JAK-STAT pathway, ^ MHCI, ^phosphodiesterase that cleave v-RNA
BM suppression, neurotoxic, alopecia, thyrois dysfunction
Entecavir :
guanosine analog, HBV DNA pol
Tenofovir
Emtricitabine |
|
|
Term
|
Definition
IFN-a
ribavirin:
1)guanosine analog ( prodrug)
2) ribavirin mono-P blocks IMP dehydrogenase ( inosine mono-P--> xanthine mono-P (halts purines)
BM suppression
Boceprevir : protease inhibitor |
|
|
Term
|
Definition
A1 agonist others: mephentermine, metaraminol, midorine
decongestant, dialte pupil, ^blood pressure |
|
|
Term
|
Definition
a2 agonist methyldopa, Guanfacine, guanabenz, brimonidine, tizanidine |
|
|
Term
Isoproterenol
D,A,F,S,T,M |
|
Definition
B agonist
Isoproterenol: B1= B2
Dobutamine : B1
albuterol, formoterol, salmeterol: B2 others: terbutaline, metaproterenol(B2) |
|
|
Term
Epinephrine Noreepinephrine Dopamine |
|
Definition
Epinephrine = all Noreepinephrine= not B2 Dopamine : D1, B1, a1 |
|
|
Term
|
Definition
D1 agonists
vasodilation and ^ renal perfusion |
|
|
Term
Phentolamine vs Phenoxybenzamine |
|
Definition
nonselective alpha blockers
Phentolamine is reversible |
|
|
Term
1st generation B-blockers |
|
Definition
1st: nonselective N-Z with --olol ending Propranolol |
|
|
Term
2nd generation B- blockers |
|
Definition
2nd: B1 blockers A--> M with --olol Atenolol |
|
|
Term
3rd generation B blockers
L,C |
|
Definition
3rd: a1 and B1 blockers Labetalol Carvedilol |
|
|
Term
|
Definition
PraZOSIN breaks rule: tamsulosin |
|
|
Term
|
Definition
yohimbine, mirtazapine- serotonin drug |
|
|
Term
|
Definition
Partial agonists Ace: b1 Pin: B1, B2 |
|
|
Term
|
Definition
|
|
Term
Mannitol
Chronic use of diuretic in general? |
|
Definition
Osmotic diuretic
No ^ in Na excretion, most of its action at PCT
Acute glaucoma, lower ICP, preserve urine vol, clear out toxins or rhabdomyolysis
Chronic: 2nd hyperaldosterone --> hypokalemia, metabolic alkalosis |
|
|
Term
|
Definition
Carbonic anhhydrase inhibitors
No: HCO3 + H --> CO2 + H2O
Excretion of HCO3, Na
renal tubular acidosis II
Use:
glaucoma (lowers aqueous humor production
Alkalinize urine to clear acidic drugs, uric acid, cysteine
Acute altitude sickness: Hyperventilation causes resp alkalosis, In brain and lungs hypoxic vasoconstriction causes edema... Drug causes acidosis, diuresis
Adverse: segments of kidney after PCT are hyper: Hyperchloremic metabolic acidosis, hypokalemia, P+ C + ^ pH urine = kidney stones, Sulfa allergy |
|
|
Term
|
Definition
Bumetanide, Torsemide, Furosemide
Ethcrynic= no sulfa allergy
All electrolytes are lost but distingished by: Ca, Mg excretion, Induces expression of cox-2--> ^ PGE2--> vasodilation
Uses: HTN, ^ Ca, ^ K, edema, Anion overdose since they will follow Na, K, Ca, Mg
Adverse: ^ uric acid (all dieuritics are weak acids and compete for excretion), Ototoxicity ( Aminoglycosides, vancomycine, cisplatin)
Drug-Drug: NSAIDs, Digoxin |
|
|
Term
|
Definition
Hydrochlorothiazides,
Chloerthalidone, Metolazone
in DCT inhibits NaCl cotransport--> Intracellular Na goes down, In the back end the Na/Ca antiporter (Na in cell, Ca towards blood) is inhanced, Ca ^ in blood, less in urine
also opens K/ATP channesl in vessels, B cells --> less insulin
Use: 1st line HTN, renal stones, Nephrogenic diabetes insipidus ( causes the more distal segments to ^ Na absorption, ^ aldosterone, ^ H20 reabsorption) before the urine hits the vasopressin section)
|
|
|
Term
Spironolactone, Eplerenone
vs
Amiloride, Triamterene |
|
Definition
K sparing Diuretics
Amiloride, Triamterene
( late DCT) Principal cells: block Na channels, less Na in = less K out
(collecting duct) Intercalated cells: Higher + potential in lumen, H (acid) cant get out
Spironolactone, Eplerenone : only difference is blocks aldosterone receptor in principal cell: which ^ Na channels on lumen, Na-K/ATPase on back end... This prevent cardiac remodeling
UseL Adjunct to k wasting diuretic, Hyperaldosterone, Hypercortisolism, Li nephrogenic Diabetes insipidus use amiloride
Adverse: acidosis, ^ K, Spironolactone antagonist of androgen receptor
|
|
|